Innovative Bioactives Demetrix specializes in developing rare and bioactive compounds, particularly cannabinoids, presenting opportunities to collaborate with health supplement, functional food, and nutraceutical brands seeking novel ingredients to enhance product efficacy.

Sustainable Production The company's focus on replicating nature's chemistry through yeast-based manufacturing methods offers a compelling value proposition for customers prioritizing environmentally friendly and cost-effective bioactive production solutions.

Strategic Industry Partnerships Demetrix's recent collaborations with Evonik and ongoing development in cannabinoid-based personal care ingredients create pathways to engage with beauty, skincare, and personal care sectors looking for innovative bioactive solutions.

Funding & Growth Having secured over $60 million in venture funding, Demetrix is positioned for expansion and new product development, creating opportunities to pitch early-stage biotech or ingredient companies aiming to incorporate advanced biotech solutions.

Emerging Market Opportunities With developments in yeast-based cannabinoid production and sampling programs for compounds like CBG, Demetrix offers prospects to partners in the CBD and medical cannabis markets seeking scalable, sustainable ingredient sources.